-+ 0.00%
-+ 0.00%
-+ 0.00%

Sinopharm Hyundai (600420.SH) subsidiary obtained bisoprolol amlodipine tablet drug registration certificate

Zhitongcaijing·08/06/2026 08:49:09
Listen to the news

Zhitong Finance App News, Sinopharm Hyundai (600420.SH) issued an announcement. Recently, Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. (Sinopharm Rongsheng for short), a wholly-owned subsidiary of the company, received the “Drug Registration Certificate” for bisoprolol amlodipine tablets approved and issued by the China Drug Administration. As an alternative treatment for hypertension, bisoprolol amlodipine tablets are suitable for patients currently taking the same single dose as the compound preparation and have good blood pressure control.